Ourania Tatsis

CIK 1789815 · EVP, Chief Reg. & Quality Off. · last filed 2026-05-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.92M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$20.57M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODTX Director $0 1 2026-05-11
VRTX EVP, Chief Reg. & Quality Off. 47,023 $444.93 $20.92M -$20.57M 48 2026-02-26
Verve Therapeutics, Inc. (VERV) Delisted Director $11.13 $0 3 2025-07-28

Recent Filings · Page 4 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-02-16 VRTX Sell (S) −320 -$95.5K EDGAR
2023-02-14 VRTX Mixed −4,647 -$1.38M EDGAR
2023-02-03 VRTX Grant (A) +24,322 $0 EDGAR
2022-08-10 VRTX Sell (S) −1,400 -$418.6K EDGAR
2022-03-21 VRTX Sell (S) −2,833 -$708.6K EDGAR
2022-02-28 VRTX Mixed −2,915 -$665.2K EDGAR
2022-02-22 VRTX Mixed −4,633 -$1.08M EDGAR
2022-02-14 VRTX Mixed −1,520 -$360.6K EDGAR
2022-02-03 VRTX Grant (A) +27,714 $0 EDGAR
2021-02-26 VRTX Tax (F) −1,036 -$225.4K EDGAR
Showing 3140 of 52
Page 4 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.